- Home
- FDBC vs TVRD Comparison
FDBC vs TVRD Comparison
Compare FDBC & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDBC
- TVRD
- Stock Information
- Founded
- FDBC 1902
- TVRD 2017
- Country
- FDBC United States
- TVRD United States
- Employees
- FDBC N/A
- TVRD N/A
- Industry
- FDBC Major Banks
- TVRD Biotechnology: Pharmaceutical Preparations
- Sector
- FDBC Finance
- TVRD Health Care
- Exchange
- FDBC Nasdaq
- TVRD Nasdaq
- Market Cap
- FDBC 250.7M
- TVRD 246.5M
- IPO Year
- FDBC N/A
- TVRD N/A
- Fundamental
- Price
- FDBC $44.99
- TVRD $3.91
- Analyst Decision
- FDBC
- TVRD Buy
- Analyst Count
- FDBC 0
- TVRD 7
- Target Price
- FDBC N/A
- TVRD $51.67
- AVG Volume (30 Days)
- FDBC 6.9K
- TVRD 160.8K
- Earning Date
- FDBC 10-22-2025
- TVRD 11-13-2025
- Dividend Yield
- FDBC 3.83%
- TVRD N/A
- EPS Growth
- FDBC 68.46
- TVRD N/A
- EPS
- FDBC 4.51
- TVRD N/A
- Revenue
- FDBC $88,597,000.00
- TVRD N/A
- Revenue This Year
- FDBC N/A
- TVRD N/A
- Revenue Next Year
- FDBC N/A
- TVRD N/A
- P/E Ratio
- FDBC $9.60
- TVRD N/A
- Revenue Growth
- FDBC 24.36
- TVRD N/A
- 52 Week Low
- FDBC $37.00
- TVRD $3.78
- 52 Week High
- FDBC $55.50
- TVRD $43.65
- Technical
- Relative Strength Index (RSI)
- FDBC 55.49
- TVRD 21.48
- Support Level
- FDBC $41.69
- TVRD $3.78
- Resistance Level
- FDBC $44.68
- TVRD $4.15
- Average True Range (ATR)
- FDBC 1.17
- TVRD 0.31
- MACD
- FDBC 0.00
- TVRD 0.90
- Stochastic Oscillator
- FDBC 90.80
- TVRD 19.40
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.